![Ingrid Jonsson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Ingrid Jonsson is the founder of STB INN AB, which was founded in 2020.
She currently holds the title of Vice President at the company.
Actieve functies van Ingrid Jonsson
Bedrijven | Functie | Begin |
---|---|---|
Strandbacka Medical
![]() Strandbacka Medical Medical SpecialtiesHealth Technology Strandbacka Medical is a Swedish company that is revolutionizing the assessment of patients with abdominal pain. The company is based in Varberg, Sweden. The company is developing a novel medical device called Perisign, which aids healthcare professionals in making a fast, objective, and correct assessment of patients with acute abdominal pain. Perisign evaluates patients within minutes and determines if they need further investigations, medical treatment, surgery, or if it is safe to go home. The device detects if the patient suffers from peritonitis, the physiological response to severe intraabdominal illness. This decreases the need for X-ray investigations and makes the subjective, manual investigation objective, increasing ER throughput. The company was founded in 2020 by Ingrid Jonsson and Andreas Jonsson. Andreas Jonsson has been the CEO since 2020. | Oprichter | 01-01-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Strandbacka Medical
![]() Strandbacka Medical Medical SpecialtiesHealth Technology Strandbacka Medical is a Swedish company that is revolutionizing the assessment of patients with abdominal pain. The company is based in Varberg, Sweden. The company is developing a novel medical device called Perisign, which aids healthcare professionals in making a fast, objective, and correct assessment of patients with acute abdominal pain. Perisign evaluates patients within minutes and determines if they need further investigations, medical treatment, surgery, or if it is safe to go home. The device detects if the patient suffers from peritonitis, the physiological response to severe intraabdominal illness. This decreases the need for X-ray investigations and makes the subjective, manual investigation objective, increasing ER throughput. The company was founded in 2020 by Ingrid Jonsson and Andreas Jonsson. Andreas Jonsson has been the CEO since 2020. | Health Technology |